IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models.
Saved in:
| Title: | IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models. |
|---|---|
| Authors: | Huang H; Chemical Engineering, University of Michigan, Ann Arbor, Michigan., Deckert J; Iksuda Therapeutics, Newcastle upon Tyne, England., Mysliwy J; Iksuda Therapeutics, Newcastle upon Tyne, England., Lodge A; Iksuda Therapeutics, Newcastle upon Tyne, England., Lutz RJ; Iksuda Therapeutics, Newcastle upon Tyne, England., Thurber GM; Chemical Engineering, University of Michigan, Ann Arbor, Michigan.; Biomedical Engineering, University of Michigan, Ann Arbor, Michigan. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2025 Dec 02; Vol. 24 (12), pp. 1845-1855. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1538-8514 |
|---|---|
| DOI: | 10.1158/1535-7163.MCT-25-0484 |
